Phase II Randomized Controlled Trial Evaluating the Necessity of Surgery in Patients With Advanced Metastatic Gastric Cancer Achieving Radiological Response After Conversion Therapy
The core of this study lies in directly addressing the most pressing clinical uncertainty in the current field: For patients with advanced metastatic gastric cancer who have achieved significant radiological remission after conversion therapy, should the addition of radical surgical intervention on top of the best medical treatment bring clear survival benefits to these patients? Answering this question is of extreme importance and urgency, directly affecting the treatment decisions, quality of life, and survival outcomes of a large number of patients.
Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer